Expert Speaker Faculty

Laura Glickman

Vice President, Research & Co- Founder

Actym Therapeutics

Andrew Miller

Vice President of Immunology and Operations

Apros Therapeutics

Sebastian Carotta

Scientific Director, Cancer Cell Signalling

Boehringer Ingelheim

Edith Perez

Chief Medical Officer

Bolt Biotherapeutics

Sean Lawler

Associate Professor of Neurosurger

Brigham and Women’s Hospital Harvard Medical School

Art Krieg

Founder, Chief Scientific Officer

Checkmate Pharmaceuticals

Kyriakos Economides

Director of Pharmacology

Codiak Biosciences

Michael Newman

President & Chief Executive Officer

Decoy Biosystems

Joshi Ramanjulu

Senior Director, Head of Project Leader Group & Senior GSK Fellow, Innate Immunity Research Unit

GSK

Sonia Macia

Director, Medical

Highlight Therapeutics

Sophie Agaugue

Director & Senior Lead - Research Operations & Scientist Project

ImCheck Therapeutics

Roxana Schillaci

Principal Researcher

Institute of Biology and Experimental Medicine (IBYME), CONICET

Adi Diab

Associate Professor, Melanoma Medical Oncology

MD Anderson

Jeremy Duvall

Associate Director Chemistry

Mersana Therapeutics

Naniye Malli Cetinbas

Senior Scientist

Mersana Therapeutics

Daniel Getts

Co-Founder & Chief Executive Officer

Myeloid Therapeutics

Nicholas Huntington

Co-Founder & Chief Scientific Officer

oNKo-innate

James Appleman

Senior Vice President R&D & Chief Scientific Officer

Primmune Therapeutics

Krysztof Brzozka

Chief Scientific Officer & Executive Vice President

Ryvu Therapeutics

Robert Andtbacka

Chief Medical Officer

Seven and Eight Biopharmaceuticals

Woody Sherman

Chief Scientific Officer

Silicon Therapeutics

Christopher Winter

Chief of R&D

Silicon Therapeutics

Martin Roelsgaard Jakobsen

Chief Scientific Officer

STipe Therapeutics

Hong Wan

Chief Executive Officer

Tallac Therapeutics

Bettina Werle

Chief Scientific Officer

Tollys

Bob Uger

Chief Scientific Officer

Trillium Therapeutics

Kate Fitzgerald

Professor, Director, Program in Innate Immunity

UMass

Diwakar Davar

Assistant Professor of Medicine

UPMC

Tatiana Novobrantseva

Co-Founder & Chief Scientific Officer

Verseau Therapeutics

Johannes Grosse

Senior Director, Drug Discovery

Vir Biotechnologies

Jim Eyles

Associate Director

AstraZeneca

Kimmy Kin-Mei Leung

Project Leader

F-star Therapeutics

Arndt Schottelius

Chief Scientific Officer

Affimed

Geoffrey Lynn

Chief Executive Officer and Co-Founder

Avidea Therapeutics

Lena Horvath

Resident Physician, Department of Hematology and Oncology

Medical University Innsbruck

David Hava

Chief Scientific Officer

Synlogic Therapeutics

Xingfeng Bao

Senior Director, Immuno-Oncology

H3 Biomedicine

Srinivas Chunduru

Vice President, Translational Medicine

Idera Pharmaceuticals

Nicolas Manel

Co-Founder and Scientific Consultant, Stimunity; Director of Research at INSERM, Group Leader

Institut Curie